Population Health Partners logo

Population Health Partners

North America, California, United States, San Francisco

Description

Population Health Partners is an investment company focused on innovative therapeutics.

Investor Profile

Population Health Partners has made 6 investments, with 1 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (50%)
  • Series C (17%)
  • Series B (17%)
  • Seed (17%)

Country Focus

  • United States (83%)
  • The Netherlands (17%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Care
  • Life Science
  • Biopharma
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Population Health Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 2
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
Maverick Capital
North America, Texas, United States, Dallas
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Mithril Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Population Health Partners often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Population Health Partners?

Metsera

New York, New York, United States

Metsera operates as a clinical-stage biopharmaceutical company.

BiopharmaHealth CareMedical
SeedApr 18, 2024
Areteia Therapeutics

Bernardsville, New Jersey, United States

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AFeb 13, 2024
Amount Raised: $75,000,000
Areteia Therapeutics

Bernardsville, New Jersey, United States

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AJul 12, 2022
Amount Raised: $350,000,000
Invivyd

Waltham, Massachusetts, United States

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

BiotechnologyPharmaceuticalTherapeutics
Series CApr 19, 2021
Amount Raised: $336,000,000
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Series AJan 14, 2021
Amount Raised: $194,412,819
Invivyd

Waltham, Massachusetts, United States

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

BiotechnologyPharmaceuticalTherapeutics
Series BNov 10, 2020
Amount Raised: $80,000,000